sulfamethoxazole has been researched along with Forestier-Certonciny Syndrome in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galezowski, N | 1 |
| Nguyen, TB | 1 |
| Blanche, P | 1 |
1 other study available for sulfamethoxazole and Forestier-Certonciny Syndrome
| Article | Year |
|---|---|
Sulfamethoxazole/trimethoprim therapy for polymyalgia rheumatica. Report of 5 cases.
Topics: Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Female; Humans; Male; Polymyalgia Rheum | 1997 |